NIH

A new protein structure may guide the development of Alzheimer's therapeutics. Read More

Vanderbilt investigators are probing the response to a bacterial toxin as a clinical assessment of immune function. Read More

Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair. Read More

Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension. Read More

In budding yeast, accumulation of a certain type of RNA in the nucleus increased life span, offering a new clue to longevity. Read More

A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening. Read More

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read More

Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found. Read More

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development. Read More

Treatment in the Neonatal Intensive Care Unit (NICU) saves millions of infants born prematurely every year. But treatment is not without cost. Painful procedures such as needle pricks can impact early brain development. Read More